A rare but serious complication of ticagrelor therapy: a case report

BACKGROUND: Ticagrelor is a widely used P2Y12 inhibitor and represents a fundamental therapeutic agent in acute coronary syndrome treatment and selected post-percutaneous coronary intervention (PCI) cases. Dyspnoea and bradycardia are the most common side effects but the latter has been reported to...

Descripción completa

Detalles Bibliográficos
Autores principales: Arioti, Manfredi, Sirianni, Giovanni, Laudisa, Maria Luisa, De Cesare, Nicoletta Bianca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7649444/
https://www.ncbi.nlm.nih.gov/pubmed/33204945
http://dx.doi.org/10.1093/ehjcr/ytaa156

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7649444/
https://www.ncbi.nlm.nih.gov/pubmed/33204945
http://dx.doi.org/10.1093/ehjcr/ytaa156

Ejemplares similares